- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 115,200 | 02.08.24 22:00:30 | +1,380 | +1,21% | 115,000 | 115,160 | 115,160 | 113,820 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 100,070 | 02.08.24 21:59:45 | -4,230 | -4,06% | 100,080 | 100,190 | 101,010 | 104,300 |
